Methotrexate effects on heterotopic bone in rats.

Area of Science:

• Biomedical Engineering
• Orthopedics
• Pharmacology

Background:

• Heterotopic bone formation is a complex process.
• Methotrexate is a chemotherapy agent with known effects on cell proliferation.

Purpose of the Study:

• To investigate the impact of high-dose methotrexate on demineralized bone matrix-induced heterotopic bone formation in growing rats.
• To determine how the timing of methotrexate administration affects bone formation.

Main Methods:

• Rats received implants of demineralized bone matrix.
• High-dose methotrexate was administered at different time points relative to implantation.
• Bone ash content, isotope uptake, and elimination rates were measured.

Main Results:

• Methotrexate arrested weight gain, particularly in younger rats.
• Pre-implantation methotrexate increased implant ash content by 33%.
• Post-implantation methotrexate reduced heterotopic bone formation by 40-22%, with less effect on orthotopic bone.

Conclusions:

• Timing of methotrexate administration influences its effect on bone formation.
• Administering methotrexate before or substantially after surgery may mitigate negative impacts on new bone formation.